Skip to main content

Profiles

Novavax

Novavax is an American biotechnology company based in Gaithersburg, Maryland.

History

Novavax sponsored the OPTIONS IX for the Control of Influenza conference from August 24-28, 2016 in Chicago, Illinois.[1]

COVID-19

On April 13, 2020, the World Health Organization (WHO) published a "Public statement for collaboration on COVID-19 vaccine development." Gale Smith, Novavax's Chief Scientist, was a signatory.[2]

Novavax is a participating organization in the Accelerating COVID-19 Therapeutic Interventions and Vaccines initiative, first announced April 17, 2020.[3]

Novavax received up to $399 million from the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of its COVID-19 vaccine candidate.[4]

Representatives of Novavax met with the Government of Canada's COVID-19 Vaccine Task Force on July 23 and December 10, 2020 to discuss its COVID-19 vaccine candidate.[5]

On February 2, 2021, Innovation, Science and Economic Development Canada signed a memorandum of understanding with Novavax to produce its COVID-19 vaccine candidate at National Research Council Canada's Biologics Manufacturing Centre.[6]

COVAX reached a supply agreement with Novavax for its Nuvaxovid product, as well as for Covovax, which the company co-developed with the Serum Institute of India (SII).[7] Novavax CEO Stanley Erck attended the One World Protected event hosted by Gavi, the Vaccine Alliance on April 15, 2021, during which COVAX was officially launched.[8]

On February 17, 2022, Health Canada authorized the Novavax COVID-19 vaccine for use in adults.[9]

Novavax sponsored the World Vaccine Congress Washington 2022, which took place from April 18-21, 2022.[10]

On July 13, 2022, the Food and Drug Administration granted an Emergency Use Authorization (EUA) for the Novavax COVID-19 vaccine.[11]

Organization

Novavax is a member or partner of:

Novavax has provided notable funding to:

  • IDSA Foundation[17]

Personnel

Name Position Notes
Stanley Erck CEO[8:1] -
Gale Smith Senior Vice President of Discovery and Pre-clinical Research, Chief Scientist[18] Protein Sciences
John Spears CEO (former)[19] Intradigm[20]

  1. OPTIONS IX Supporters. OPTIONS IX. Retrieved July 7, 2017, from https://web.archive.org/web/20170707010655/http://2016.isirv.org/options-ix-supporters ↩︎

  2. Jasarevic, T. (2020, April 16). Public statement for collaboration on COVID-19 vaccine development. World Health Organization. http://archive.today/2020.10.04-153106/https://www.who.int/news-room/detail/13-04-2020-public-statement-for-collaboration-on-covid-19-vaccine-development ↩︎

  3. ACTIV. National Institutes of Health (NIH). Retrieved April 1, 2022, from http://archive.today/2022.01.11-042823/https://www.nih.gov/research-training/medical-research-initiatives/activ ↩︎

  4. Our portfolio. CEPI. Retrieved October 21, 2022, from https://web.archive.org/web/20221021070613/https://cepi.net/research_dev/our-portfolio/ ↩︎

  5. COVID-19 Vaccine Task Force Registry of Interests. (2023, March 27). Innovation, Science and Economic Development Canada. http://archive.today/2023.07.09-180656/https://ised-isde.canada.ca/site/biomanufacturing/en/covid-19-vaccine-task-force/covid-19-vaccine-task-force-registry-interests ↩︎

  6. Backgrounder – Government of Canada investments in COVID-19 vaccines, therapeutics and biomanufacturing capacity. (2021, February 2). Innovation, Science and Economic Development Canada. http://archive.today/2021.02.17-210959/https://www.canada.ca/en/innovation-science-economic-development/news/2021/02/backgrounder--government-of-canada-investments-in-covid-19-vaccines-and-biomanufacturing-capacity.html ↩︎

  7. Gavi COVAX AMC 2021 Investment Opportunity Launch Event. (2022, January 29). Gavi, the Vaccine Alliance. https://web.archive.org/web/20220820112357/https://www.gavi.org/gavi-covax-amc-launch-event-april-2021 ↩︎

  8. The Gavi COVAX AMC Investment Opportunity Launch Event Participant List. (2021). Gavi, the Vaccine Alliance; USAID; U.S. Department of State. https://web.archive.org/web/20220821050428/https://www.gavi.org/sites/default/files/covid/covax/Investment-Opportunity-Launch-Participant-List.pdf ↩︎ ↩︎

  9. Parkhill, M. (2022, February 17). Novavax vaccine authorized for use in Canada. CTV News. http://archive.today/2022.02.17-170358/https://www.ctvnews.ca/health/coronavirus/novavax-vaccine-authorized-for-use-in-canada-1.5785244 ↩︎

  10. Sponsors & exhibitors | Vaccine Congress USA. (2022, April 21). World Vaccine Congress Washington 2022. http://archive.today/2022.04.22-012231/https://www.terrapinn.com/conference/world-vaccine-congress-washington/sponsors-and-exhibitors.stm ↩︎

  11. Capobianco, A. (2022, July 13). Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted. Food and Drug Administration. https://web.archive.org/web/20220713201410/https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-emergency-use-novavax-covid-19-vaccine-adjuvanted ↩︎

  12. AVAC Member Organizations. (2021). Adult Vaccine Access Coalition. http://archive.today/2022.07.08-060340/https://adultvaccinesnow.org/our-membership/avac-member-organizations/ ↩︎

  13. BIO Member Directory. Biotechnology Innovation Organization. Retrieved September 30, 2022, from https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory ↩︎

  14. Membership. (2022). European Federation of Pharmaceutical Industries and Association. https://web.archive.org/web/20220701031757/https://www.efpia.eu/about-us/membership/ ↩︎

  15. Current Members. MCDC. Retrieved January 3, 2023, from http://archive.today/2023.01.03-195328/https://www.medcbrn.org/current-members/ ↩︎

  16. Strategic Partners. National Foundation for Infectious Diseases. Retrieved July 16, 2022, from http://archive.today/2022.07.16-073224/https://www.nfid.org/about-nfid/strategic-partners/ ↩︎

  17. Home. IDSA Foundation. Retrieved October 8, 2022, from https://web.archive.org/web/20221008025156/https://idsafoundation.org/ ↩︎

  18. Meet Gale E. Smith, PhD. Novavax. Retrieved April 17, 2023, from https://web.archive.org/web/20230417112829/https://www.novavax.com/who-we-are/leadership/gale-e-smith-phd ↩︎

  19. Ex-chief of Novavax hired as Intradigm CEO. (2002, November 28). The Baltimore Sun, C2. https://www.newspapers.com/image/248431447/?terms=Intradigm&match=1 ↩︎

  20. Intradigm appoints John A. Spears Chairman and CEO. (2002, December 2). PharmaBiz. http://archive.today/2023.03.04-202058/http://test.pharmabiz.com/news/intradigm-appoints-john-a-spears-chairman-and-ceo-12922 ↩︎